Immunoprecise Antibodies Ltd (IPA) — Free Cash Flow Generation Index
Immunoprecise Antibodies Ltd (IPA) has a Free Cash Flow Generation Index of -0.62x as of October 2020. Free cash flow of $-274.98K represents -1% of operating cash flow ($440.23K). See IPA working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Immunoprecise Antibodies Ltd Free Cash Flow Generation Index (2016–2016)
Historical FCF Generation Index trend for Immunoprecise Antibodies Ltd across 1 annual periods. Explore Immunoprecise Antibodies Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Immunoprecise Antibodies Ltd (2016–2016)
Year-by-year Free Cash Flow Generation Index for Immunoprecise Antibodies Ltd. For the full company profile including market capitalisation, see IPA stock market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.94x | $266.61K | $284.09K | $17.48K | — |